MEGAN MICEK: Open Payments
NPI 1780466052 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 15 payments from 7 companies in 2025. Trend: 2023 $34 · 2024 $352 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| Novo Nordisk Inc | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Astellas Pharma US Inc | 1 | $34 |
| Seqirus USA Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: QULIPTA, Ozempic, CAPLYTA, Veozah, Fluad, Rybelsus, Cologuard Collection Kit, JARDIANCE.
Industry payments across NE — which companies pay providers there.
